Benzinga | Dec 17, 2021 07:49AM EST

Goldman Sachs Initiates Coverage On AbbVie with Neutral Rating, Announces Price Target of $113

Goldman Sachs analyst Chris Shibutani initiates coverage on AbbVie (NYSE:ABBV) with a Neutral rating and announces Price Target of $113.